Ellis Investment Partners, LLC Amgen Inc Transaction History

Ellis Investment Partners, LLC

$502 Million
Q3 2024

A detailed history of Ellis Investment Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ellis Investment Partners, LLC holds 3,269 shares of AMGN stock, worth $927,121. This represents 0.21% of its overall portfolio holdings.

Number of Shares

3,269

Previous 3,484 6.17%

Holding current value

$927,121

Previous $1.09 Million 3.22%

% of portfolio

0.21%

Previous 0.23%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $66,516 - $72,536	-215 Reduced 6.17%	3,269 $1.05 Million
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $9,196 - $11,175	35 Added 1.01%	3,484 $1.09 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $70,443 - $85,034	262 Added 8.22%	3,449 $980,000
Q4 2023 Jan 29, 2024	BUY	$255.7 - $288.46 $7,415 - $8,365	29 Added 0.92%	3,187 $917,000
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $3,498 - $4,343	16 Added 0.51%	3,158 $848,000
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $10,927 - $12,921	51 Added 1.65%	3,142 $697,000
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $3,612 - $4,403	16 Added 0.52%	3,091 $747,000
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $3,206 - $4,074	-14 Reduced 0.45%	3,075 $807,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $3,142 - $3,544	14 Added 0.46%	3,089 $696,000
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $1,614 - $1,797	7 Added 0.23%	3,075 $748,000
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $30,039 - $33,232	137 Added 4.67%	3,068 $742,000
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $285,989 - $327,288	1,438 Added 96.32%	2,931 $659,000
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $4,882 - $5,720	23 Added 1.56%	1,493 $317,000
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $179,155 - $198,760	-767 Reduced 34.29%	1,470 $358,000
Q1 2021 May 03, 2021	SELL	$221.91 - $258.6 $227,235 - $264,806	-1,024 Reduced 31.4%	2,237 $557,000
Q4 2020 Jan 20, 2021	BUY	$216.38 - $257.67 $432 - $515	2 Added 0.06%	3,261 $750,000
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $6,100 - $6,784	-26 Reduced 0.79%	3,259 $828,000
Q2 2020 Jul 13, 2020	BUY	$197.81 - $242.74 $13,451 - $16,506	68 Added 2.11%	3,285 $838,000
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $182 - $241	1 Added 0.03%	3,217 $636,000
Q4 2019 Jan 07, 2020	BUY	$189.21 - $243.2 $189 - $243	1 Added 0.03%	3,216 $772,000
Q3 2019 Oct 09, 2019	BUY	$174.11 - $208.62 $4,352 - $5,215	25 Added 0.78%	3,215 $621,000
Q2 2019 Jul 24, 2019	BUY	$166.7 - $195.41 $166 - $195	1 Added 0.03%	3,190 $594,000
Q1 2019 Apr 25, 2019	SELL	$180.87 - $203.88 $109 Million - $123 Million	-602,745 Reduced 99.47%	3,189 $611,000
Q1 2019 Apr 24, 2019	BUY	$180.87 - $203.88 $104 Million - $118 Million	576,399 Added 1951.58%	605,934 $605,000
Q1 2019 Apr 22, 2019	BUY	$180.87 - $203.88 $4.77 Million - $5.37 Million	26,347 Added 826.44%	29,535 $911,000
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $568,739 - $663,901	3,188 New	3,188 $620,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellis Investment Partners, LLC with notifications on news.

Account

Ellis Investment Partners, LLC Amgen Inc Transaction History